AMLX 8-K 2026-08-06

Amylyx Pharmaceuticals, Inc. (AMLX) 8-K dated 2026-08-06 — accession 0001193125-26-336670. This URL is the filing, not the AMLX hub.

Amylyx Pharmaceuticals, Inc. (AMLX) is a biotechnology company listed on US.

Amylyx Pharmaceuticals, Inc. filed a 8-K on 2026-08-06. Accession 0001193125-26-336670.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AMLX revenue for 2025-12-31 was $0. Net income was -$144.7M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AMLX currently screens at market cap $561.6M.

Not investment advice. The AMLX SEC hub lists recent forms. The stock page is the research view.